Du Vigneaud, V., Ressler, C., Trippett, S., THE SEQUENCE OF AMINO ACIDS IN OXYTOCIN, WITH A PROPOSAL FOR THE STRUCTURE OF OXYTOCIN. J. Biol. Chem. 205:2 (1953 Dec), 949–957.
Bárez-López, S., Scanlon, L., Murphy, D., Greenwood, M.P., Imaging the Hypothalamo-Neurohypophysial System. Neuroendocrinology 113:2 (2023), 168–178.
Gimpl, G., Fahrenholz, F., The Oxytocin Receptor System: Structure, Function, and Regulation. Physiol. Rev. 81:2 (2001), 629–683.
Marazziti, D., Dell'Osso, B., Baroni, S., Mungai, F., Catena, M., Rucci, P., et al. A relationship between oxytocin and anxiety of romantic attachment. Clin. Pract. Epidemiol. Ment. Health, 2006.
Shamay-Tsoory, S., Young, L.J., Understanding the Oxytocin System and Its Relevance to Psychiatry. Biol. Psychiatry 79:3 (2016), 150–152.
Hall, S.S., Lightbody, A.A., McCarthy, B.E., Parker, K.J., Reiss, A.L., Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology 37:4 (2012), 509–518.
Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Maréchal, P., Pequeux, C., et al. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology [internet]. 32:4 (2007), 407–410.
Jin, Y., Song, D., Yan, Y., Quan, Z., Qing, H., The Role of Oxytocin in Early-Life-Stress-Related Neuropsychiatric Disorders. IJMS., 24(13), 2023, 10430.
Jiang, J., Zou, Y., Xie, C., Yang, M., Tong, Q., Yuan, M., et al. Oxytocin alleviates cognitive and memory impairments by decreasing hippocampal microglial activation and synaptic defects via OXTR/ERK/STAT3 pathway in a mouse model of sepsis-associated encephalopathy. Brain Behav. Immun. 114 (2023), 195–213.
Sikich, L., Kolevzon, A., King, B.H., McDougle, C.J., Sanders, K.B., Kim, S.J., et al. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. N Engl J Med. 385:16 (2021), 1462–1473.
Andari, E., Duhamel, J.R., Zalla, T., Herbrecht, E., Leboyer, M., Sirigu, A., Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. PNAS 107:9 (2010), 4389–4394.
Neumann, I.D., Landgraf, R., Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 35:11 (2012 Nov), 649–659.
Tabak, B.A., Leng, G., Szeto, A., Parker, K.J., Verbalis, J.G., Ziegler, T.E., et al. Advances in human oxytocin measurement: challenges and proposed solutions. Mol. Psychiatry, 2022, November 2021.
Jurek, B., Neumann, I.D., The Oxytocin Receptor: From Intracellular Signaling to Behavior. Physiological Reviews [internet]. 98:3 (2018), 1805–1908.
Tabak, B.A., Teed, A.R., Castle, E., Dutcher, J.M., Meyer, M.L., Bryan, R., et al. Null results of oxytocin and vasopressin administration across a range of social cognitive and behavioral paradigms: Evidence from a randomized controlled trial. Psychoneuroendocrinology 107 (2019), 124–132.
Yamasue, H., Okada, T., Munesue, T., Kuroda, M., Fujioka, T., Uno, Y., et al. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial. Mol Psychiatry. 25:8 (2020), 1849–1858.
Lefevre, A., Mottolese, R., Dirheimer, M., Mottolese, C., Duhamel, J.R., Sirigu, A., A comparison of methods to measure central and peripheral oxytocin concentrations in human and non-human primates. Sci Rep., 7(1), 2017, 17222.
MacLean, E.L., Wilson, S.R., Martin, W.L., Davis, J.M., Nazarloo, H.P., Carter, C.S., Challenges for measuring oxytocin: The blind men and the elephant?. Psychoneuroendocrinology 107 (2019), 225–231.
Grønbæk-Thorsen, F., Jensen, C., Østergaard, J., Møller, L.H., Gammelgaard, B., Comparison of external calibration and isotope dilution LC-ICP-MS/MS for quantitation of oxytocin and its selenium analogue in human plasma. Anal. Bioanal. Chem. 413:26 (2021), 6479–6488.
Erikson, D.W., Blue, S.W., Kaucher, A.V., Shnitko, T.A., LC–MS/MS measurement of endogenous oxytocin in the posterior pituitary and CSF of macaques: A pilot study. Peptides, 140(503), 2021.
Franke, A.A., Li, X., Dabalos, C., Lai, J.F., Improved oxytocin analysis from human serum and urine by orbitrap ESI-LC-HRAM-MS. Drug Test. Anal. 12:6 (2020), 846–852.
Liu, D., Han, X., Liu, X., Cheng, M., He, M., Rainer, G., et al. Measurement of ultra-trace level of intact oxytocin in plasma using SALLE combined with nano-LC–MS. J. Pharm. Biomed. Anal. 173 (2019), 62–67.
Zhang, G., Zhang, Y., Fast, D.M., Lin, Z., Steenwyk, R., Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography-tandem mass spectrometry assay. Anal. Biochem. 416:1 (2011), 45–52.
Brandtzaeg, O.K., Johnsen, E., Roberg-Larsen, H., Seip, K.F., MacLean, E.L., Gesquiere, L.R., et al. Proteomics tools reveal startlingly high amounts of oxytocin in plasma and serum. Sci Rep., 6(1), 2016, 31693.
Franke, A.A., Li, X., Menden, A., Lee, M.R., Lai, J.F., Oxytocin analysis from human serum, urine, and saliva by orbitrap liquid chromatography–mass spectrometry. Drug Test. Anal. 11:1 (2019), 119–128.
Richter D. Synthesis, Processing, and Gene Structure of Vasopressin and Oxytocin. In: Progress in Nucleic Acid Research and Molecular Biology. Elsevier; 1983. p. 245–66.
CLSI. Clinical and laboratory standards institute EP06: evaluation of linearity of quantitative measurement procedures. 2020;.
CLSI. Clinical and laboratory standards institute EP05-A3: evaluation of precision of quantitative measurement methods. 2014;.
CLSI. EP21-A Estimation of total analytical error for clinical laboratory methods.
Linko, S., Örnemark, U., Kessel, R., Taylor, P.D.P., Evaluation of uncertainty of measurement in routine clinical chemistry - Applications to determination of the substance concentration of calcium and glucose in serum. Clin. Chem. Lab. Med. 40:4 (2002), 391–398.
Audunsdottir, K., Quintana, D.S., Oxytocin's dynamic role across the lifespan. Aging Brain., 2, 2022, 100028.
